Research

New Ovia Health Report Highlights Growing Demand for Family-Friendly Workplace Benefits in the U.S.

A recent report released by Ovia Health by Labcorp, titled “Future of Family Friendly 2024: Benefits That Matter,” offers insights into the preferences of U.S. workers regarding family-friendly workplace benefits. “This report indicates we are witnessing a shift in what employees seek in terms of family-friendly benefits, and they’re willing to change employers to find them,” said Jenny Carillo, Ph.D., President of Ovia.…

Lisa Health Study Unveils Workplace Realities: Menopause’s Impact on Women’s Careers

SRI (formerly Stanford Research Institute) and Lisa Health, the company behing the Midday menopause app, recently published a study shedding light on the often-overlooked challenges faced by menopausal women in the workforce. The study, conducted across the United States with 351 working women aged 40–65, aimed to understand the intersection of menopause and professional life. “There is a notable gap between desired…

Gynica Commences First-in-Human Clinical Trial for Novel IntraVag Treatment for Endometriosis

Gynica, a clinical-stage biotech startup focused on women’s health, has announced the initiation of a first-in-human Phase 1 clinical trial for a novel Endometriosis treatment. Led by renowned expert Prof. Felice Petraglia, the study aims to evaluate Gynica’s non-hormonal, intra-vaginal drug candidates using the IntraVag intra-vaginal drug delivery platform. Endometriosis, affecting over 200 million women worldwide, is characterized by the abnormal growth…

Bloomer Tech’s Alicia Chong Rodriguez: “Government funding can be a catalyst that enables bold ideas to meet the needs of women.”

The recent announcement of $100 million in funding for women’s health research, made by First Lady Jill Biden at the Advanced Research Agency for Health (ARPA-H) event, marks a significant milestone in the advancement of women’s healthcare. Among the attendees when the announcement was made was Alicia Chong Rodriguez, Founder and CEO of Bloomer Tech, a healthcare technology company dedicated to cardiovascular…

Innovate UK Grant Supports Female-Led Startup Building Diverse Biomarker Database

SökerData, a London-based, female-founded digital health startup, has been awarded a substantial portion of a £6.2 million grant by Innovate UK. The startup is set to advance the field of drug discovery through its innovative biomarker database project, aimed at enhancing disease characterisation and drug development efficiency. With a focus on bridging the gap in clinical trials and improving representation across demographics,…

NIH Awards $2.3M to Study ViTrack’s Impact on Maternal and Child Health During Pregnancy

Dynocardia, in partnership with NYC Health + Hospitals, is launching a new study funded by a $2.3M grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. The study focuses on the non-invasive, wearable blood pressure and heart monitor, ViTrack, to enhance the diagnosis and early detection of hypertensive diseases of pregnancy (HDP), including preeclampsia.…

FHI 360 Initiates Phase I Clinical Trial for Biodegradable Contraceptive Implant

FHI 360 has commenced a pivotal Phase I clinical trial in the Dominican Republic for Casea S, a novel biodegradable contraceptive implant, marking the first trial of its kind in over two decades. Aimed at offering a long-term contraception solution, Casea S is engineered to release the synthetic hormone etonogestrel, commonly used in other contraceptive implants, to prevent pregnancy for a duration…

UK Hospital Initiates World-First Non-Hormonal Endometriosis Drug Trial

A pioneering drug trial has commenced at a UK hospital, marking a significant milestone in the quest for innovative endometriosis treatments. This Phase II research study, led by the Gynaecology and Research and Development team at NNUH, is examining the safety and effectiveness of a novel antibody, AMY109, developed by Chugai Pharmaceutical Co Ltd. Aimed at reversing the debilitating symptoms of endometriosis…